Resonance Health is excited to be exhibiting at the Annual Meeting of the British Association for the Study of the Liver in England this week – 14th – 18th September 2014.
The British Association for the Study of the Liver is dedicated to the knowledge and understanding of the biology and pathology of the liver for the optimal care of patients.
This meeting gives Resonance Health the opportunity to meet with scientists, clinicians and members of the pharmaceutical industry specialising in the liver. Both FerriScan and the new HepaFat-Scan technologies are being exhibited.
Information regarding BASL can be found here.